CHEMOSENSITIZATION OF BLADDER CARCINOMA CELLS BY BCL-xL ANTISENSE OLIGONUCLEOTIDES
- 1 August 2001
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 166 (2) , 461-469
- https://doi.org/10.1016/s0022-5347(05)65964-2
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Is irrelevant cleavage the price of antisense efficacy?Pharmacology & Therapeutics, 2000
- Antisense Oligonucleotides in CancerBioDrugs, 2000
- Inhibition of Bcl-xL expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuliOncogene, 1999
- EXPRESSION OF BCL-2 AND BCL-X IN BLADDER CANCERJournal of Urology, 1998
- Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancerUrological Research, 1997
- Inhibition of High Affinity Basic Fibroblast Growth Factor Binding by OligonucleotidesPublished by Elsevier ,1995
- Site and Mechanism of Antisense Inhibition by C-5 Propyne OligonucleotidesBiochemistry, 1995
- Phosphorothioate Oligodeoxynucleotides Bind to Basic Fibroblast Growth Factor, Inhibit Its Binding to Cell Surface Receptors, and Remove It from Low Affinity Binding Sites on Extracellular MatrixPublished by Elsevier ,1995
- Antisense Gene Inhibition by Oligonucleotides Containing C-5 Propyne PyrimidinesScience, 1993
- RNase H-mediated inhibition of translation by antisense oligodeoxyribo-nucleotides: use of backbone modification to improve specificityGene, 1992